Skip to main content

Remote Job Finders (RJF)

BMS’ Latest Cuts in New Jersey Will Affect 223 Employees

2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.

Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees

Eisai’s cuts will affect 121 employees across the Japanese company’s U.S. operations, including 57 people at its American headquarters in Nutley, New Jersey. A company spokesperson said the pharma remains fully committed to the U.S. market.

Mission Nixes Preclinical Studies, Falls Back on Clinical Candidates

Mission Therapeutics is down to its clinical assets MTX652 and MTX325, which work by disabling a key enzyme that interferes with the cell’s normal process of removing faulty or dysfunctional mitochondria.
Scroll to top